![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Janssen Pharmaceutica Nv Beerse Be, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Bromperidol, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1999-009 - Rev 04
This Chemical Type CEP, issued on February 18, 2014, remains in force until July 13, 2022, ensuring its reliability within the pharmaceutical industry.
Substance Number 1178 associated with this CEP further emphasizes